2-NBDG | CAS#186689-07-6 | contrast agent

MedKoo Cat#: 584465 | Name: 2-NBDG

Description:

WARNING: This product is for research use only, not for human or veterinary use.

2-NBDG is a fluorescent derivative of glucose whose uptake is competitively inhibited by D-glucose, but not L-glucose or sucrose, in E. coli. It has been used to monitor glucose uptake by bacteria and live mammalian cells and in tumor biopsies.

Chemical Structure

2-NBDG

CAS#186689-07-6

Theoretical Analysis

MedKoo Cat#: 584465

Name: 2-NBDG

CAS#: 186689-07-6

Chemical Formula: C12H14N4O8

Exact Mass: 342.0812

Molecular Weight: 342.26

Elemental Analysis: C, 42.11; H, 4.12; N, 16.37; O, 37.40

Price and Availability

Size	Price	Availability
5mg	USD 120.00	Ready to ship
10mg	USD 190.00	Ready to ship
25mg	USD 350.00	Ready to ship
50mg	USD 550.00	Ready to ship
100mg	USD 950.00	Ready to ship
200mg	USD 1,650.00	Ready to ship

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

2-NBDG; 2NBDG; 2 NBDG

IUPAC/Chemical Name

2-(N-(7-nitro-2,1,3-benzoxadiazol-4-yl)amino)-2-deoxyglucopyranoside

InChi Key

GVEBOQDOPLERMC-BGCUHRRXSA-N

InChi Code

InChI=1S/C12H14N4O8/c17-3-6-10(18)11(19)9(12(20)23-6)13-4-1-2-5(16(21)22)8-7(4)14-24-15-8/h1-2,6,9-13,17-20H,3H2/t6-,9-,10-,11-,12?/m1/s1

SMILES Code

OC1[C@H](NC2=CC=C([N+]([O-])=O)C3=NON=C32)[C@H]([C@@H]([C@@H](CO)O1)O)O

Appearance

Red-orange solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Product Data

Product Data

Certificate of Analysis

View CoA: current batch, Lot# T22D06P07

QC Data

View QC data: current batch, Lot# T22D06P07

Safety Data Sheet (SDS)

View Safety Data Sheet (SDS)

Instruction

View handling instruction

Biological target:

2-NBDG, a fluorescent D-glucose analog, is a fluorescent indicator for monitoring glucose uptake into living cells.

In vitro activity:

Results of high-resolution and widefield imaging of 2-NBDG based molecular contrast in model cell-culture systems are shown in Figure 1. Figure 1 (a) shows the uptake of 2-NBDG in 1483 oral squamous carcinoma cell line; fluorescence is predominantly localized to the cytoplasm. The fluorescence signal from 2-NBDG is significantly higher than the cellular autofluorescence signal from unlabeled cells. Figure 1(b) demonstrates labeling of cells in a tissue culture phantom following topical delivery of 2-NBDG. Reference: Int J Cancer. 2009 Jun 1;124(11):2634-42. https://pubmed.ncbi.nlm.nih.gov/19173294/

In vivo activity:

Circulating breast cancer cells with increased uptake of 2-NBDG were detected in the blood samples of tumor-bearing mice following incubation of the blood samples with 2-NBDG and magnetic separation using magnetic beads conjugated with anti-EpCAM IgG. Circulating breast cancer cells with uptake of 2-NBDG were detected not only in the blood samples from the mice bearing visible SKBR-3 xenograft tumors, but also in the blood samples from the mice with no visible tumors after implantation of SKBR-3 tumor cells (Fig. 2a). Circulating breast cancer cells with uptake of 2-NBDG were also detected in the blood samples from the mice bearing MDA-MB-231 xenograft tumors (Fig. 2b), or BT474 xenograft tumors (Fig. 2c). Reference: J Fluoresc. 2013 Jan;23(1):213-20. https://pubmed.ncbi.nlm.nih.gov/23054302/

	Solvent	mg/mL	mM
Solubility
	DMF	10.0	29.22
	DMSO	37.4	109.30
	Ethanol	11.5	33.60
	PBS (pH 7.2)	10.0	29.22
	Water	3.5	10.23

Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 342.26 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:

1. Nitin N, Carlson AL, Muldoon T, El-Naggar AK, Gillenwater A, Richards-Kortum R. Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose. Int J Cancer. 2009 Jun 1;124(11):2634-42. doi: 10.1002/ijc.24222. PMID: 19173294; PMCID: PMC2700039. 2. Thekkek N, Maru DM, Polydorides AD, Bhutani MS, Anandasabapathy S, Richards-Kortum R. Pre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett's-associated neoplasia during confocal imaging. Technol Cancer Res Treat. 2011 Oct;10(5):431-41. doi: 10.7785/tcrt.2012.500220. PMID: 21895028; PMCID: PMC4527376. 3. Cai H, Peng F. 2-NBDG fluorescence imaging of hypermetabolic circulating tumor cells in mouse xenograft model of breast cancer. J Fluoresc. 2013 Jan;23(1):213-20. doi: 10.1007/s10895-012-1136-z. Epub 2012 Oct 9. PMID: 23054302; PMCID: PMC4592774. 4. Tsytsarev V, Maslov KI, Yao J, Parameswar AR, Demchenko AV, Wang LV. In vivo imaging of epileptic activity using 2-NBDG, a fluorescent deoxyglucose analog. J Neurosci Methods. 2012 Jan 15;203(1):136-40. doi: 10.1016/j.jneumeth.2011.09.005. Epub 2011 Sep 14. PMID: 21939688; PMCID: PMC3221836.

In vitro protocol:

In vivo protocol:

1. Cai H, Peng F. 2-NBDG fluorescence imaging of hypermetabolic circulating tumor cells in mouse xenograft model of breast cancer. J Fluoresc. 2013 Jan;23(1):213-20. doi: 10.1007/s10895-012-1136-z. Epub 2012 Oct 9. PMID: 23054302; PMCID: PMC4592774. 2. Tsytsarev V, Maslov KI, Yao J, Parameswar AR, Demchenko AV, Wang LV. In vivo imaging of epileptic activity using 2-NBDG, a fluorescent deoxyglucose analog. J Neurosci Methods. 2012 Jan 15;203(1):136-40. doi: 10.1016/j.jneumeth.2011.09.005. Epub 2011 Sep 14. PMID: 21939688; PMCID: PMC3221836.

1. K. Yoshioka, H. Takahashi, T. Homma, et al. A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli. Biochimica et Biophysica Acta 1289(1), 5-9 (1996). 2. K. Yamada, M. Saito, H. Matsuoka, et al. A real-time method of imaging glucose uptake in single, living mammalian cells. Nature Protocols 2(3), 753-763 (2007). 3. N. Nitin, A. L. Carlson, T. Muldoon, et al. Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose. International Journal of Cancer 124(11), 1-20 (2009). 4. N. Thekkek, D. M. Maru, A. D. Polydorides, et al. Pre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett’s-associated neoplasia during confocal imaging. Technol.Cancer Res.Treat. 10(5), 431-441 (2011).